Catalent Biologics Content

  1. Critical Path For Gene Therapy: AAV Analytical Lifecycle Considerations 12/2/2025

    Explore considerations for phase-appropriate AAV characterization and release activities from pre-clinical to late-phase products. Review validation challenges and paths for maturation of analytics.

  2. Advanced iPSC Workflows: Accelerating Cell Therapy Development 9/30/2025

    Beyond offering our GMP-compliant iPS cells, we develop superior workflows for gene editing and differentiation to provide competitive platforms to our partners and accelerate their therapeutic programs.

  3. UpTempo℠: Seamless Transitions From Bench To CGT Applications 6/19/2025

    Accelerate cell and gene therapy development with high-yield, regulatory-compliant plasmid DNA manufacturing that shortens timelines, minimizes risks, and streamlines your supply chain.

  4. Leveraging Advanced Tech, Proven Expertise From Cell Line Development And Beyond 1/28/2025

    Learn how our expertise and advanced capabilities provide customized analytical solutions that ensure quality, precision, and regulatory compliance for your biotherapeutics.

  5. Quantifying Cell Response With Duplex RT-qPCR

    Discover a new potency bioassay using RT-qPCR to assess relative transcription activity, and learn more about the advantages and limitations of transcriptional assays versus reporter gene assays.